Stroke is the first cause of death in women and the second leading cause of death in men in industrialized countries. In Asia, every year an estimated 500 thousand people experience a stroke. Therefore recognizing stroke risk factors and managing them appropriately is key to designing primary prevention strategies in non-stroke populations and secondary prevention to avoid recurrent strokes. This research was cross sectional study to describe profile stroke patients in Arifin Achmad hospital Riau Province. Research data was taken through questionnaire and patient medical records. In this study, stroke patients in Arifin Achmad Hospital were mostly <60 years old, 65.80% and male sex 64.50%. The proportion of hypertension is 90.80%. Diabetes mellitus 7.90%, dyslipidemia 63.20%, smoking 21.10%, obesity 32.90%, and sedentary life 73.70%.
Management in patients with type 2 diabetes mellitus (DM) is aimed diabetic control required antidiabetic drugs(OAD). The aim of this study was to know data about the profile of diabetics control in patients with type 2 diabetesmellitus followed in department of endocrinology Arifin Achmad General Hospital Pekanbaru. The type of researchwas descriptive. The samples are 96 people included all patients with type 2 DM according to inclusion criteria. Theidentity patients and patients knowledge were determined using questionnaire, used of antidiabetics drugs and diabeticcontrol were detemined using medical record. The characteristics of patients with type 2 DM were most at group ofage 50-59 years (45,8%), female sex (58,3%), duration of DM 1-5 years (52,1%), complication of diabetic neuropathy(25%) and frequency of the Doctor once a month (64,6%). The used OAD predominant oral antidiabetic drugs (83%)combinations sulfonylureas and biguanid (73,7%), combinations oral antidiabetic drugs with insulin (14%) arecombinations biguanid with long acting insulin (69,2%) and intensive insulin (3%) are long acting insulin with rapidacting insulin (66,6%). Diabetic control of patients with type 2 DM are fasting blood glucose, post prandial 2 hoursblood glucose, total cholesterol, LDL and HDL was bad (68%, 74%, 46,9%, 61,5% and 70,8%). This researchshowed that used of antidiabetic drugs was not satisfactory of diabetic control.
Erupsi obat alergi merupakan bentuk reaksi simpang obat tipe B yang terjadi di kulit yang disebabkan oleh penggunaan obat. Tujuan dari penelitian ini adalah untuk mengetahui gambaran pasien erupsi obat alergi di Poliklinik Kulit dan Kelamin RSUD Arifin Achmad Provinsi Riau pada periode 1 Januari 2011-31 Desember 2015. Penelitian ini merupakan penelitian deskriptif retrospektif dengan menggunakan data sekunder berupa rekam medis. Sampel yang digunakan sebanyak 351 sampel yang telah sesuai dengan kriteria inklusi dan eksklusi. Pasien erupsi obat alergi paling banyak ditemukan pada perempuan (58,97%) dibandingkan dengan laki-laki. Kelompok usia 41-60 tahun (30,20%) merupakan kelompok usia pasien erupsi obat alergi terbanyak. Penyakit endokrin (10,54%) merupakan penyakit penyerta yang paling banyak ditemukan pada penelitian ini dan riwayat alergi makanan ditemukan pada 4 kasus (1,14%). Bentuk erupsi yang paling sering ditemukan adalah eritroderma (23,93%). Obat penyebab erupsi obat alergi yang paling banyak ditemukan adalah antibiotik (21,65%).
Abstrak. Stroke adalah penyakit akibat gangguan peredaran darah otak yang dipengaruhi oleh banyak faktor risiko. Stroke merupakan penyebab utama disabilitas. Stroke secara umum diklasifikasikan menjadi stroke iskemik atau stroke non hemoragik dan stroke hemoragik. Salah satu faktor risiko terjadinya stroke adalah obesitas. Tujuan penelitian ini adalah untuk mengetahui gambaran obesitas pada pasien stroke akut di RSUD Arifin Achmad Provinsi Riau Periode Januari–Desember 2019. Desain penelitian yang digunakan adalah penelitian deskriptif dengan rancangan cross sectional menggunakan data sekunder rekam medis pasien stroke akut di RSUD Arifin Achmad Provinsi Riau Periode Januari-Desember 2019 dengan jumlah sampel sebanyak 115 kasus. Hasil penelitian menunjukkan stroke banyak terjadi pada usia terbanyak terjadi pada rentang usia 51-65 sebanyak 60 kasus (52,2%). Jenis kelamin terbanyak yaitu laki-laki sebanyak 67 kasus (58,3%). Jenis stroke terbanyak adalah stroke hemoragik yaitu 62 kasus (53,9%). Terdapat 65 kasus (56,5%) pasien obesitas, sebanyak 34 kasus (52,3%) adalah stroke hemoragik. Kesimpulan dari penelitian ini adalah obesitas lebih banyak terjadi pada stroke hemoragik dibanding stroke iskemik.Kata kunci: obesitas, strokeAbstract. Stroke is a disease caused by the interrupted of blood supply to the brain which can be influenced by several risk factors. Stroke is a major cause of disability. Stroke is generally classified as ischemic or non-hemorrhagic and hemorrhagic stroke. One of those risk factors of stroke is obesity. The aim of this study was to describe obesity in acute stroke patients at Arifin Achmad Regional Hospital of Riau Province in January- December 2019. This was a descriptive study design with cross sectional study method while using medical records of the acute stroke patient’s at Arifin Achmad Regional Hospital of Riau Province in January to December 2019. There were 115 cases fulfilled the criteria. The results show that the majority happened within 51-65 years age group with 60 cases (52,2%) and frequently in male as much as 67 cases (58,3%). Most patients had hemorrhagic stroke with 62 cases (53,9%). In 65 cases (56,5%) of obese patients cases, 34 cases (52,3%) were hemorrhagic strokes. The conclusion of this study is that obesity more commonly occurs in hemorrhagic stroke types compared to the ischemic.Keywords: acute stroke, obesity
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.